Deferasirox and deferiprone remove cardiac iron in the iron-overloaded gerbil
- 1 November 2006
- journal article
- research article
- Published by Elsevier in Translational Research
- Vol. 148 (5) , 272-280
- https://doi.org/10.1016/j.trsl.2006.05.005
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- LPI-labile plasma iron in iron overloadBest Practice & Research Clinical Haematology, 2005
- Nitroxyl triggers Ca2+ release from skeletal and cardiac sarcoplasmic reticulum by oxidizing ryanodine receptorsCell Calcium, 2005
- Myocardial iron loading in transfusion-dependent thalassemia and sickle cell diseaseBlood, 2004
- The oral iron chelator ICL670A (deferasirox) does not protect myocytes against doxorubicinFree Radical Biology & Medicine, 2003
- Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trialThe Lancet, 2003
- Characterization of Fe2+ and Fe3+ transport by iron-loaded cardiac myocytesToxicology, 1997
- Results of Long-Term Iron-Chelating TherapyActa Haematologica, 1996
- Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia MajorNew England Journal of Medicine, 1994
- SAFETY OF ORAL IRON CHELATOR L1The Lancet, 1989
- Iron in the heartThe American Journal of Medicine, 1971